Dietary fiber, gut microbiota, and host immunity: the immunomodulatory roles of short-chain fatty acids
- 1edical School of Health, Zhengzhou Health College, Zhengzhou, Henan, China
Abstract
Short-chain fatty acids (SCFAs) are a class of key metabolites produced by the gut microbiota through the fermentation of indigestible components such as dietary fiber. They primarily include acetate, propionate, and butyrate. In recent years, a large body of research has revealed that SCFAs are not only an important energy source for colonic epithelial cells but also key signaling molecules linking the gut microbiota to the host immune system. SCFAs play a central role in immune regulation. This review summarizes the production and characteristics of SCFAs. It explores the multifaceted roles of SCFAs in regulating immune homeostasis and inflammatory responses. Through key mechanisms such as activation of G protein-coupled receptors (GPCRs), inhibition of histone deacetylases (HDACs), and metabolic reprogramming, SCFAs broadly regulate the differentiation, function, and inflammatory responses of immune cells, maintain intestinal barrier integrity, and induce an anti-inflammatory state. At the same time, the manuscript analyzes the molecular mechanisms by which SCFAs contribute to inflammatory bowel disease, metabolic disorders, tumor immunity, and neuro-immune diseases through multi-organ pathways such as the “gut-liver axis” and the “gut-brain axis”. In addition, this article summarizes treatment strategies targeting SCFAs, including dietary interventions, probiotics, prebiotics, and fecal microbiota transplantation. It also discusses the current challenges in this field and outlines future directions, with the aim of providing new insights for the prevention and treatment of immune-related diseases.
Related
- Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration
- Early-life microbiota direct an epithelial S100 program required for neonatal immunity
- Gut Enterococcus faecium derived leucic acid mediates the antiobesity effect of dietary fiber
- From high-salt diet to cancer immunity: gut microbiota and immune system interactions and their mechanisms
- Valorization of orange peel by-products via ultrasound-pretreated enzymatic extraction of soluble dietary fiber: Structural and functional characterization
BibTeX
@article{hou2026dietary,
title = {{Dietary fiber, gut microbiota, and host immunity: the immunomodulatory roles of short-chain fatty acids}},
author = {Xiaoli Hou and Yan Li and Weiwei Mu and Huiqin Wang and Shaoping Ji},
journal = {Frontiers in Nutrition},
year = {2026},
month = oct,
doi = {10.3389/fnut.2026.1941474},
url = {https://doi.org/10.3389/fnut.2026.1941474},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dietary fiber, gut microbiota, and host immunity: the immunomodulatory roles of short-chain fatty acids
AU - Xiaoli Hou
AU - Yan Li
AU - Weiwei Mu
AU - Huiqin Wang
AU - Shaoping Ji
PY - 2026
DA - 2026/10/23
JO - Frontiers in Nutrition
DO - 10.3389/fnut.2026.1941474
UR - https://doi.org/10.3389/fnut.2026.1941474
AB - Short-chain fatty acids (SCFAs) are a class of key metabolites produced by the gut microbiota through the fermentation of indigestible components such as dietary fiber. They primarily include acetate, propionate, and butyrate. In recent years, a large body of research has revealed that SCFAs are not only an important energy source for colonic epithelial cells but also key signaling molecules linking the gut microbiota to the host immune system. SCFAs play a central role in immune regulation. This review summarizes the production and characteristics of SCFAs. It explores the multifaceted roles of SCFAs in regulating immune homeostasis and inflammatory responses. Through key mechanisms such as activation of G protein-coupled receptors (GPCRs), inhibition of histone deacetylases (HDACs), and metabolic reprogramming, SCFAs broadly regulate the differentiation, function, and inflammatory responses of immune cells, maintain intestinal barrier integrity, and induce an anti-inflammatory state. At the same time, the manuscript analyzes the molecular mechanisms by which SCFAs contribute to inflammatory bowel disease, metabolic disorders, tumor immunity, and neuro-immune diseases through multi-organ pathways such as the “gut-liver axis” and the “gut-brain axis”. In addition, this article summarizes treatment strategies targeting SCFAs, including dietary interventions, probiotics, prebiotics, and fecal microbiota transplantation. It also discusses the current challenges in this field and outlines future directions, with the aim of providing new insights for the prevention and treatment of immune-related diseases.
SN - 2296-861X
ER -